Drugs and dementia: Pharmacotherapy and decision making by primary caregivers

Amy M. Haddad

Drugs and dementia: Pharmacotherapy and decision making by primary caregivers

Amy M. Haddad

Interdisciplinary Studies

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.

Original language	English (US)
Title of host publication	Ethical Foundations of Palliative Care for Alzheimer Disease
Publisher	The Johns Hopkins University Press
Pages	330-342
Number of pages	13
ISBN (Print)	0801878705, 9780801898396
State	Published - Dec 1 2010

All Science Journal Classification (ASJC) codes

Arts and Humanities(all)

Fingerprint Dive into the research topics of 'Drugs and dementia: Pharmacotherapy and decision making by primary caregivers'. Together they form a unique fingerprint.

Cite this

@inbook{f65aa62953764da68fb08625acfa7bd7,

title = "Drugs and dementia: Pharmacotherapy and decision making by primary caregivers",

abstract = "The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.",

author = "Haddad, {Amy M.}",

year = "2010",

month = dec,

day = "1",

language = "English (US)",

isbn = "0801878705",

pages = "330--342",

booktitle = "Ethical Foundations of Palliative Care for Alzheimer Disease",

publisher = "The Johns Hopkins University Press",

}

TY - CHAP

T1 - Drugs and dementia

T2 - Pharmacotherapy and decision making by primary caregivers

AU - Haddad, Amy M.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.

AB - The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.

UR - http://www.scopus.com/inward/record.url?scp=33749334230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749334230&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:33749334230

SN - 0801878705

SN - 9780801898396

SP - 330

EP - 342

BT - Ethical Foundations of Palliative Care for Alzheimer Disease

PB - The Johns Hopkins University Press

ER -